If you have diabetes and your feet burn, tingle, or feel numb — often worse at night — you're describing painful diabetic peripheral neuropathy, one of the most common complications of diabetes. The good news that doesn't get said often enough: it's treatable, and when the usual pills fall short, the options no longer stop there.
Why diabetic neuropathy hits the feet first
Persistently high blood sugar damages the small nerves over time, and the longest nerves in the body — the ones reaching your feet — are affected earliest. That's why symptoms typically begin as burning, tingling, numbness, or shooting pain in the toes and soles, often spreading upward in a "stocking" pattern and intensifying at night.
Managing blood sugar is foundational and helps slow further damage. But once the pain is established, blood-sugar control alone usually isn't enough to relieve it — which is where treatment for the pain itself begins.
The standard first step: medications, and their ceiling
Clinical guidelines from the American Academy of Neurology recommend starting with oral medications — gabapentinoids (gabapentin, pregabalin), certain antidepressants (duloxetine, amitriptyline), and related agents (AAN practice guideline on treatment of painful diabetic neuropathy). The American Diabetes Association's position statement takes a similar stepwise view (ADA position statement on diabetic neuropathy).
These are a reasonable first step. But they have a real ceiling: for many people they provide only partial relief, and side effects such as drowsiness, dizziness, and unsteadiness lead a substantial number to reduce or stop them. If you've cycled through pills and still hurt, you are not out of options — you're at the point where a different kind of treatment has the strongest evidence.
When pills aren't enough: a proven next step
For painful diabetic neuropathy that persists despite medication, high-frequency (10 kHz) spinal cord stimulation is now supported by randomized-trial evidence and is FDA-approved for this specific condition. In the SENZA-PDN randomized controlled trial, 79% of patients treated with stimulation were responders, compared with just 5% of those on conventional medical management alone — and, importantly, the stimulation group's neurological function did not worsen (randomized clinical trial, JAMA Neurology).
Two details make that result even more striking. By six months, 81% of the medication-only group chose to cross over to stimulation — while none of the stimulation patients crossed the other way. And the benefits were durable, sustained through 24 months of follow-up. This is no longer an experimental idea; it's an evidence-backed, approved treatment for exactly the patients medications leave behind.
What the treatment actually involves
The part that reassures most patients is that you try it before you commit. A thin lead is placed under imaging guidance, and you wear an external stimulator for several days while living your normal life, judging for yourself whether it meaningfully reduces your pain. Only if it does do you proceed to a small, permanent implant — placed under the skin like a pacemaker, controlled from an app or remote. If the trial doesn't help, the lead is simply removed, with no permanent change.
For pain confined to a single nerve region, peripheral nerve stimulation (PNS) works on the same reversible, trial-first principle, targeting the specific affected nerve.
If you're weighing this against staying on medication, our companion piece on gabapentin's long-term side effects is worth a read.
Chronic foot pain from diabetes is not something you simply have to accept. Our 2-minute neuropathy assessment is a plain-language place to start, and you can explore the treatments we offer for diabetic and other nerve pain in more detail.
